Study: Epileptic Patients Report Subjective Benefits from Cannabis

ONTARIO, CANADA — Patients with epilepsy frequently experiment with cannabis and most report experiencing subjective benefits following their use of the substance, according to datapublished online ahead of print in the journal Epilepsy & Behavior.

Canadian researchers surveyed the experiences of over 300 adult patients admitted to an epilepsy monitoring unit over a 14-month period. More than half of the respondents acknowledged having tried cannabis and over a third reported having used it in the past year.

Cannabis use was associated with perceived reductions in seizure frequency, reduced stress, improved sleep and better memory/concentration.

Clinical trial data reports that cannabinoids, in particular cannabidiol (CBD), possess anti-convulsant activity in patients with intractable forms of the disease.